Bank of Montreal’s Maravai LifeSciences MRVI Stock Holding History

Bank of Montreal’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$371K	Hold	59,452	–	–	﹤0.01%	2644
2026 Q1	$168K	Hold	59,452	–	–	﹤0.01%	2990
2025 Q4	$193K	Hold	59,452	–	–	﹤0.01%	2863
2025 Q3	$171K	Buy	59,452 +29,383	+98%	+$75K	﹤0.01%	2819
2025 Q2	$72.5K	Buy	+30,069	New	+$63.2K	﹤0.01%	3071
2025 Q1	–	Sell	-77,679	Closed	-$423K	–	3651
2024 Q4	$423K	Buy	+77,679	New	+$500K	﹤0.01%	2332
2024 Q3	–	Sell	-27,306	Closed	-$284K	–	4106
2024 Q2	$284K	Buy	27,306 +3,291	+14%	+$28.4K	﹤0.01%	2774
2024 Q1	$210K	Sell	24,015 -9,000	-27%	-$60.9K	﹤0.01%	3023
2023 Q4	$222K	Buy	+33,015	New	+$213K	﹤0.01%	3063
2023 Q2	–	Sell	-50,478	Closed	-$713K	–	4187
2023 Q1	$713K	Buy	+50,478	New	+$725K	﹤0.01%	2255
2022 Q4	–	Sell	-26,336	Closed	-$674	–	4179
2022 Q3	$674	Buy	26,336 +2,881	+12%	+$72.3K	﹤0.01%	2400
2022 Q2	$654	Buy	23,455 +6,892	+42%	+$218K	﹤0.01%	2541
2022 Q1	$591K	Buy	16,563 +1,986	+14%	+$66.6K	﹤0.01%	2709
2021 Q4	$613K	Sell	14,577 -656	-4%	-$26.6K	﹤0.01%	2244
2021 Q3	$738K	Sell	15,233 -10,727	-41%	-$523K	﹤0.01%	2657
2021 Q2	$1.12M	Buy	25,960 +14,985	+137%	+$581K	﹤0.01%	2414
2021 Q1	$365K	Buy	+10,975	New	+$364K	﹤0.01%	2835

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

OAM

Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

First Eagle Investment Management New York $59.9B AUM 27.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal's MRVI Position: Q2 2026 in Review

Bank of Montreal held its Maravai LifeSciences (MRVI) position steady in Q2 2026 at 59,452 shares worth $371K. The position accounts for ﹤0.01% of the portfolio, ranked #2644.

Bank of Montreal first reported a position in MRVI in Q1 2021 and has held it in 17 quarters since. The position peaked at $1.12M in Q2 2021. 162 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

Bank of Montreal held 59,452 shares of Maravai LifeSciences worth $371K as of Q2 2026.
Bank of Montreal left its Maravai LifeSciences share count unchanged in Q2 2026.
Maravai LifeSciences made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #2644 holding.
Bank of Montreal first reported a position in Maravai LifeSciences in Q1 2021 and has held it in 17 quarters since.
Bank of Montreal's Maravai LifeSciences position peaked at $1.12M in Q2 2021.
162 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.